Merck Acquiring Cubist, Focusing On Hospital Care

By |2014-12-08T17:32:59+00:00December 8th, 2014|Uncategorized|

ig pharma Merck (NYSE:MRK) agreed to buy antibiotic specialist Cubist Pharmaceuticals (NASDAQ:CBST) Monday in a deal valued at $9.5 billion. Cubist soared 35% in the stock market today, while Merck dropped a fraction. Merck is acquiring Cubist for $102 a share in cash, yielding an equity value of $8.4 billion, plus $1.1 billion in net [...]

Read More
Comments Off on Merck Acquiring Cubist, Focusing On Hospital Care

Studyops Awarded Fibromyalgia Clinical Trial , Screening will begin in December

By |2014-11-26T16:21:09+00:00November 26th, 2014|Pharma News|

Studyops, San Francisco, CA. 11/26/2014, and the Center for Occupational Health received an award for a new RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE-CONTROLLED Clinical Trial for patients with Fibromyalgia. Dr Viladimir Bokarius will be the lead principal investigator for the project, which will take place in our Richmond California location. Studyops continues to be the Sponsor's choice [...]

Read More
Comments Off on Studyops Awarded Fibromyalgia Clinical Trial , Screening will begin in December
Go to Top